​CRS (CardioRenal Status)

Diabetics and hypertensive patients have a threefold increased risk of sudden cardiac death and around a third are at risk of kidney disease. This is why it is so important to recognise the risk of these complications as early as possible.

The routine "check-up" at the GP/diabetologist often comes too late because only advanced diseases can be diagnosed. For example, the routine test only shows altered protein levels when your kidneys are already irreversibly damaged. Similarly, tests for atherosclerosis in heart failure are only carried out if there is a concrete suspicion of the disease. However, the disease is often already present.

The perfect management: recognising kidney and cardiovascular diseases 2-5 years before diagnosis with the protexam CRS test!

The protexam CRS test consists of:

- protexam KCU test for early detection of kidney disease and

- protexam HCU test for early detection of an increased risk of heart attack due to arteriosclerosis or heart failure.

Only a timely diagnosis can significantly improve the success of a therapy and prevent both kidney and cardiovascular diseases.